PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study shows type 2 diabetics can live longer than people without the disease

A commonly prescribed diabetes drug could offer surprising health benefits to non-diabetics

2014-08-08
(Press-News.org) Patients treated with a drug widely prescribed for type 2 diabetes can live longer than people without the condition, a large-scale study involving over 180,000 people has shown.

The findings indicate that a drug known as metformin, used to control glucose levels in the body and already known to exhibit anticancer properties, could offer prognostic and prophylactic benefits to people without diabetes.

Published in a leading diabetes journal, Diabetes, Obesity and Metabolism by scientists from Cardiff University, the study set out to compare the survival of diabetes patients prescribed with metformin with patients prescribed with another common diabetes drug called sulphonylurea.

Importantly, the life expectancy of these cohorts was also compared against non-diabetics who were matched based on criteria that included age, gender, same general practice, smoking status and clinical status.

"What we found was illuminating," said lead author Professor Craig Currie from Cardiff University's School of Medicine.

"Patients treated with metformin had a small but statistically significant improvement in survival compared with the cohort of non-diabetics, whereas those treated with sulphonylureas had a consistently reduced survival compared with non-diabetic patients. This was true even without any clever statistical manipulation.

"Surprisingly, the findings indicate that this cheap and widely prescribed diabetic drug may have beneficial effects not only on patients with diabetes but also for people without, and interestingly, people with type 1 diabetes. Metformin has been shown to have anti-cancer and anti-cardiovascular disease benefits. It can also reduce pre-diabetics' chances of developing the disease by a third.

"This does not mean that people with type 2 diabetes get off Scott free. Their disease will progress and they will be typically switched to more aggressive treatments. People lose on average around eight years from their life expectancy after developing diabetes. The best way to avoid the condition altogether is by keeping moderately lean and taking some regular light exercise."

In the next phase of the research, Professor Currie plans to investigate how patients prescribed with metformin as a first line therapy can best be treated thereafter to ensure that their life expectancy can be brought closer in line with the national average.

Type 2 diabetes affects 8% of the US population and 6% of the UK population.

Effective glucose control in diabetics is important in reducing the risk of microvascular complications such as stroke or coronary artery disease. The stymying of these conditions can initially be achieved through diet and exercise, but glucose lowering medication is required in most patients with progressing diabetes.

Metformin is recommended as first line therapy for type 2 diabetes in the current American Diabetes Association and the European Association for the study of diabetes guidelines. The National Institute for Health and Care Excellence (NICE) also recommend the drug.

Sulphonylureas are commonly prescribed if metformin is deemed by practitioners to be an unsuitable course for treatment. Unlike metformin, sulphonylureas can cause weight gain, hypoglycaemia and an impaired recovery after heart attacks. Conversely, metformin is associated with beneficial effects, including improved cardiac health and an ability to fight the onset of certain cancers.

Data used in study came from the UK Clinical Practice Research Datalink, representing around 10% of the UK population, where researchers identified 78,241 patients who were prescribed metformin as a first-line therapy and 12,222 patients prescribed a sulphonylurea as a first-line therapy. These were then each matched against non-diabetic patient.

INFORMATION: The study was funded by Bristol Myers-Squibb.


ELSE PRESS RELEASES FROM THIS DATE:

White dwarfs crashing into neutron stars explain loneliest supernovae

White dwarfs crashing into neutron stars explain loneliest supernovae
2014-08-08
A research team led by astronomers and astrophysicists at the University of Warwick have found that some of the Universe's loneliest supernovae are likely created by the collisions of white dwarf stars into neutron stars. Dr Joseph Lyman from the University of Warwick is the lead researcher on the paper, The progenitors of calcium-rich transients are not formed in situ, published today by the journal Monthly Notices of the Royal Astronomical Society (to appear on astro-ph 8 August 2014). "Our paper examines so-called `calcium-rich' transients" says Dr Lyman. "These ...

Water-polluting anxiety drug reduces fish mortality

2014-08-08
A drug that is commonly used to treat anxiety in humans and which regularly finds its way into surface waters through wastewater effluence has been shown to reduce mortality rates in fish. The results, which have been published today, 8 August, in IOP Publishing's journal Environmental Research Letters, may have significant implications for existing standard ecotoxicological tests, which predominantly focus on harmful effects of water contaminants and ignore the potential benefits. By improving the health of an aquatic organism, a certain pharmaceutical drug may alter ...

The Lancet Neurology: study highlights pervasive problem of sleep deprivation in astronauts

2014-08-08
Astronauts suffer considerable sleep deficiency in the weeks leading up to and during spaceflight, according to the most extensive study of sleep during spaceflight ever conducted, published in The Lancet Neurology journal. Fatigue and sleep deficiency are common complaints among astronauts, but this is the most comprehensive study to include both objective evaluation of sleep (via an actigraph, a device worn on the wrist which records sleep and wake cycles) and subjective evaluations (via a daily diary recording alertness and sleep quality). Researchers from Brigham ...

Air traffic growth set to outpace carbon reduction efforts

2014-08-08
Carbon reduction efforts in the airline industry will be outweighed by growth in air-traffic, even if the most contentious mitigation measures are implemented, according to new research by the University of Southampton. Even if proposed mitigation measures are agreed upon and put into place, air traffic growth-rates are likely to out-pace emission reductions, unless demand is substantially reduced. "There is little doubt that increasing demand for air travel will continue for the foreseeable future," says co-author and travel expert Professor John Preston. "As a result, ...

Ten-year study highlights sleep deficiency and sleep medication use in astronauts

2014-08-08
BOSTON, MA – In an extensive study of sleep monitoring and sleeping pill use in astronauts, researchers from Brigham and Women's Hospital (BWH) Division of Sleep and Circadian Disorders, Harvard Medical School, and the University of Colorado found that astronauts suffer considerable sleep deficiency in the weeks leading up to and during space flight. The research also highlights widespread use of sleeping medication use among astronauts. The study, published in The Lancet Neurology on August 8, 2014, recorded more than 4,000 nights of sleep on Earth, and more than ...

New test predicts individual's risk of a second kidney stone

2014-08-08
Washington, DC (August 7, 2014) — A new tool that takes multiple factors into account can accurately predict how likely a patient who experienced a painful kidney stone will develop another one in the future. The tool, which is described in an upcoming issue of the Journal of the American Society of Nephrology (JASN), could help patients and their doctors determine whether preventive measures are needed. Kidney stones are common and affect approximately 6% to 9% of the population. The greatest concern of patients who have experienced a kidney stone is whether this excruciating ...

Boston Marathon bombing caregivers still grappling with tragedy one year later

2014-08-08
Boston, MA (August, 2014) – Nearly a year after the 2013 Boston Marathon bombings, hospital staff, first responders and medical volunteers who cared for the injured and dying were still struggling to put the experience behind them, according to a Schwartz Center for Compassionate Healthcare report that describes eight confidential sessions held to help caregivers process their emotions and feelings in the aftermath of this horrific event. The 90-minute Schwartz Center Rounds sessions – sponsored by the Schwartz Center in collaboration with the Conference of Boston Teaching ...

Slowing brain functions linked to increased risk of stroke, death

2014-08-07
Cognitive abilities such as memory and attention are not only important after a stroke but also before; according to research published in the American Heart Association journal Stroke. Previous studies have shown poor cardiovascular health can increase the risk of cognitive impairment such as problems in memory and learning. However, the opposite idea that cognitive impairment may impact cardiovascular health, specifically stroke, was not established before. "Most clinical studies observe cognitive impairment after a stroke event, said Kumar Rajan, Ph.D., lead author ...

Neck manipulation may be associated with stroke

2014-08-07
Treatments involving neck manipulation may be associated with stroke, though it cannot be said with certainty that neck manipulation causes strokes, according to a new scientific statement published in the American Heart Association's journal Stroke. Cervical artery dissection (CD) is a small tear in the layers of artery walls in the neck. It can result in ischemic stroke if a blood clot forms after a trivial or major trauma in the neck and later causes blockage of a blood vessel in the brain. Cervical artery dissection is an important cause of stroke in young and middle-aged ...

New treatment successful for the Mal de Debarquement Syndrome

2014-08-07
People who suffer from a rare illness, the Mal de Debarquement Syndrome (MdDS), now have a chance for full recovery thanks to treatment developed by researchers at the Icahn School of Medicine at Mount Sinai. Their findings were published online in the July issue of Frontiers in Neurology. People often feel a sensation of movement, called Mal de Debarquement, after they have finished boating, surfing or a sea voyage. The symptoms usually disappear within hours, but in some people, and more frequently in women, symptoms can continue for months or years, causing fatigue, ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Study shows type 2 diabetics can live longer than people without the disease
A commonly prescribed diabetes drug could offer surprising health benefits to non-diabetics